Physician profile
Robert S Marcus
NPI 1528123734
$955.70
in general payments reported to CMS, 2019-2025
11 companies · $153 in 2025
The $153 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $471 · 2020: $39.23 · 2021: $12.42 · 2022: $78.20 · 2023: $119 · 2024: $82.92 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $354.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rikco International, LLC | $434.00 | 2019 | |
| Stryker Corporation | $117.21 | 2025 | Infinity Adaptis, Prostep Mica |
| Horizon Therapeutics Plc | $116.43 | 2019-2022 | |
| Medtronic, INC. | $60.14 | 2023 | Intellis Adaptivestim |
| Acera Surgical, INC. | $46.90 | 2023-2025 | Restrata Wound Matrix |
| Treace Medical Concepts, INC. | $38.12 | 2022-2025 | |
| Amgen INC. | $33.88 | 2024 | Krystexxa |
| Grt US Holding, INC. | $30.09 | 2022 | |
| Convatec INC. | $29.89 | 2023 | |
| Smith+Nephew, INC. | $24.99 | 2024 | Renasys Go V2 Home |
| Tactile Systems Technology INC | $24.05 | 2024 | Entre Plus, Flexitouch Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Marcus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.